Results 271 to 280 of about 570,529 (349)
Guide RNA structure design enables combinatorial CRISPRa programs for biosynthetic profiling. [PDF]
Fontana J+10 more
europepmc +1 more source
Multiplexed promoter and gene editing in wheat using a virus-based guide RNA delivery system. [PDF]
Wang W+6 more
europepmc +1 more source
Sustained localized presentation of RNA interfering molecules from in situ forming hydrogels to guide stem cell osteogenic differentiation [PDF]
Minh Khanh Nguyen+4 more
openalex +1 more source
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani+14 more
wiley +1 more source
Precise in vivo RNA base editing with a wobble-enhanced circular CLUSTER guide RNA. [PDF]
Reautschnig P+16 more
europepmc +1 more source
Cooperative Tertiary Interaction Network Guides RNA Folding
Reza Behrouzi+4 more
openalex +1 more source
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez+17 more
wiley +1 more source
CRISPR-Cas guide RNA indel analysis using CRISPResso2 with Nanopore sequencing data. [PDF]
McFarlane GR, Polanco JVC, Bogema D.
europepmc +1 more source
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen+12 more
wiley +1 more source
A platform to deliver single and bi-specific Cas9/guide RNA to perturb genes in vitro and in vivo. [PDF]
Li YJ+16 more
europepmc +1 more source